Table 3 Characteristics of the COVID-19 patients according to the tertiles of TyG
From: Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19
TyG tertiles | P | |||
|---|---|---|---|---|
T1 (7.5–8.6) (N = 50) | T2 (8.7–9.1) (N = 51) | T3 (9.2–10.7) (N = 50) | ||
Age, years | 53 (32) | 66 (22) | 67.5 (18) | 0.006 |
Male, No. (%) | 21 (42%) | 25 (49%) | 32 (64%) | 0.080 |
White blood Cell count, × 109/L | 4.5 (1.9) | 5.5 (4.0) | 6.5 (4.7) | 0.000 |
Neutrophil count, × 109/L | 2.7 (1.5) | 4.0 (4.6) | 4.6 (5.0) | 0.000 |
Lymphocyte count, × 109/L | 1.2 ± 0.5 | 1.0 ± 0.6 | 0.9 ± 0.6 | 0.018 |
Aspartate aminotransferase, U/L | 23 (18) | 29 (13) | 33.5 (29) | 0.016 |
Lactate dehydrogenase, U/L | 240.0 (130.0) | 293.0 (176.0) | 332.0 (245.0) | 0.000 |
Creatinine, μmol/L | 73.1 ± 27.6 | 78.8 ± 31.6 | 86.9 ± 34.3 | 0.089 |
Uric acid, μmol/L | 260.2 ± 80.6 | 266.3 ± 122.4 | 287.2 ± 129.2 | 0.455 |
C-reactive protein, mg/L | 11.6 (37.9) | 39.8 (70.3) | 37.9 (127.6) | 0.005 |
Ferritin, ug/L | 377.8 (470.4) | 642.7 (1247.2) | 1008.5 (1154.1) | 0.000 |
TNFα, pg/mL | 7.4 (2.2) | 8.8 (5.5) | 9.4 (6.3) | 0.012 |
Fasting glucose, mmol/L | 5.5 (1.2) | 6.5 (2.1) | 10.8 (7.8) | 0.000 |
Triglyceride, mmol/L | 0.9 (0.3) | 1.4 (0.5) | 1.8 (1.0) | 0.000 |
TyG | 8.3 (0.4) | 8.9 (0.3) | 9.6 (0.6) | 0.000 |